A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients



Status:Completed
Conditions:Renal Impairment / Chronic Kidney Disease
Therapuetic Areas:Nephrology / Urology
Healthy:No
Age Range:18 - Any
Updated:8/3/2016
Start Date:December 2000
End Date:March 2006

Use our guide to learn which trials are right for you!

A Randomized, Open-label Study Comparing the Effects of Low-dose Cyclosporine vs Cyclosporine Withdrawal on Renal Function in Kidney Transplant Patients Treated With CellCept and Daclizumab

This study will compare kidney function in kidney transplant patients following treatment
with various combinations of Zenapax, CellCept, corticosteroids, and Neoral (Cyclosporine).
The anticipated time on study treatment is 6-12 months, and the target sample size is 500+
individuals.


Inclusion Criteria:

- adult patients greater than 18 years of age

- recipients of primary kidney transplant

- single-organ recipients (kidney only)

Exclusion Criteria:

- previous treatment with Zenapax

- history of malignancy (except localized skin cancer)
We found this trial at
9
sites
9338
mi
from
Adelaide,
Click here to add this to my saved trials
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
Charleston, South Carolina 29412
1064
mi
from
Charleston, SC
Click here to add this to my saved trials
1118
mi
from
Falls Church, VA
Click here to add this to my saved trials
1047
mi
from
Gainesville, FL
Click here to add this to my saved trials
1270
mi
from
Livingston, NJ
Click here to add this to my saved trials
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
1339
mi
from
San Francisco, CA
Click here to add this to my saved trials